08/28/2025 9:41 AM | Fulcrum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2025 8:01 AM | Adage Capital Management, L.P. (Filed by) Fulcrum Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/29/2025 7:34 AM | Fulcrum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/29/2025 7:39 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025 4:33 PM | Fulcrum Therapeutics (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025 6:05 AM | Fulcrum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2025 6:10 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/17/2025 8:35 AM | BlackRock, Inc. (Filed by) Fulcrum Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/25/2025 6:21 AM | Fulcrum Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025 6:05 AM | Fulcrum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/25/2025 6:10 AM | Fulcrum Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/12/2025 8:32 AM | Adage Capital Management, L.P. (Filed by) Fulcrum Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/28/2025 3:15 PM | Fulcrum Therapeutics (Issuer) Musso Alan A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 6:00 AM | Fulcrum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 3:50 PM | Fulcrum Therapeutics (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
12/23/2024 3:30 PM | Fulcrum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 3:53 PM | Fulcrum Therapeutics (Subject) Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/14/2024 3:25 PM | Fulcrum Therapeutics (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024 5:15 AM | Fulcrum Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024 6:05 AM | Fulcrum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 6:10 AM | Fulcrum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024 2:51 PM | Fulcrum Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 10:49 AM | Fulcrum Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/07/2024 10:37 AM | FMR LLC (Filed by) Fulcrum Therapeutics (Subject)
| Form SC 13G/A | |